These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 30924352)
1. GPX3 hypermethylation in gastric cancer and its prognostic value in patients aged over 60. Zhou C; Pan R; Li B; Huang T; Zhao J; Ying J; Duan S Future Oncol; 2019 Apr; 15(11):1279-1289. PubMed ID: 30924352 [TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of glutathione peroxidase 1 (GPX1) down-regulation and correlation with aberrant promoter methylation in human gastric cancer. Min SY; Kim HS; Jung EJ; Jung EJ; Jee CD; Kim WH Anticancer Res; 2012 Aug; 32(8):3169-75. PubMed ID: 22843889 [TBL] [Abstract][Full Text] [Related]
3. Silencing of glutathione peroxidase 3 through DNA hypermethylation is associated with lymph node metastasis in gastric carcinomas. Peng DF; Hu TL; Schneider BG; Chen Z; Xu ZK; El-Rifai W PLoS One; 2012; 7(10):e46214. PubMed ID: 23071548 [TBL] [Abstract][Full Text] [Related]
4. Association between GPX3 promoter methylation and malignant tumors: A meta-analysis. Zhou C; Hu H; Zheng Z; Chen C; Li Y; Li B; Duan S Pathol Res Pract; 2019 Jul; 215(7):152443. PubMed ID: 31085009 [TBL] [Abstract][Full Text] [Related]
5. Downregulation of glutathione peroxidase 3 is associated with lymph node metastasis and prognosis in cervical cancer. Zhang X; Zheng Z; Yingji S; Kim H; Jin R; Renshu L; Lee DY; Roh MR; Yang S Oncol Rep; 2014 Jun; 31(6):2587-92. PubMed ID: 24788695 [TBL] [Abstract][Full Text] [Related]
6. Site-specific Hypermethylation of RUNX3 Predicts Poor Prognosis in Gastric Cancer. Wang N; Sui F; Ma J; Su X; Liu J; Yao D; Shi B; Hou P; Yang Q Arch Med Res; 2016 May; 47(4):285-92. PubMed ID: 27664488 [TBL] [Abstract][Full Text] [Related]
7. Frequent epigenetic suppression of tumor suppressor gene glutathione peroxidase 3 by promoter hypermethylation and its clinical implication in clear cell renal cell carcinoma. Liu Q; Jin J; Ying J; Sun M; Cui Y; Zhang L; Xu B; Fan Y; Zhang Q Int J Mol Sci; 2015 May; 16(5):10636-49. PubMed ID: 25970749 [TBL] [Abstract][Full Text] [Related]
8. Analysis of the clinical significance of DNA methylation in gastric cancer based on a genome-wide high-resolution array. Fang WL; Chen MH; Huang KH; Chang SC; Lin CH; Chao Y; Lo SS; Li AF; Wu CW; Shyr YM Clin Epigenetics; 2019 Nov; 11(1):154. PubMed ID: 31675985 [TBL] [Abstract][Full Text] [Related]
9. GPX3 promoter is methylated in chronic myeloid leukemia. Yao DM; Zhou JD; Zhang YY; Yang L; Wen XM; Yang J; Guo H; Chen Q; Lin J; Qian J Int J Clin Exp Pathol; 2015; 8(6):6450-7. PubMed ID: 26261521 [TBL] [Abstract][Full Text] [Related]
10. SLC22A16 upregulation is an independent unfavorable prognostic indicator in gastric cancer. Zhao W; Wang Y; Yue X Future Oncol; 2018 Sep; 14(21):2139-2148. PubMed ID: 29698084 [TBL] [Abstract][Full Text] [Related]
11. Hypermethylation and downregulation of glutathione peroxidase 3 are related to pathogenesis of melanoma. Chen H; Zheng Z; Kim KY; Jin X; Roh MR; Jin Z Oncol Rep; 2016 Nov; 36(5):2737-2744. PubMed ID: 27600457 [TBL] [Abstract][Full Text] [Related]
12. Identification of genes epigenetically silenced by CpG methylation in human gastric carcinoma. Jee CD; Kim MA; Jung EJ; Kim J; Kim WH Eur J Cancer; 2009 May; 45(7):1282-1293. PubMed ID: 19195878 [TBL] [Abstract][Full Text] [Related]
13. Detection of aberrant hypermethylated spastic paraplegia-20 as a potential biomarker and prognostic factor in gastric cancer. Zhang H; Song Y; Xia P; Cheng Y; Guo Q; Diao D; Wang W; Wu X; Liu D; Dang C Med Oncol; 2014 Feb; 31(2):830. PubMed ID: 24381142 [TBL] [Abstract][Full Text] [Related]
14. Hypermethylation and clinicopathological significance of RASAL1 gene in gastric cancer. Chen H; Pan Y; Cheng ZY; Wang Z; Liu Y; Zhao ZJ; Fan H Asian Pac J Cancer Prev; 2013; 14(11):6261-5. PubMed ID: 24377515 [TBL] [Abstract][Full Text] [Related]
15. Clinical significance of the methylated cytosine-phosphate-guanine sites of protocadherin-10 promoter for evaluating the prognosis of gastric cancer. Deng J; Liang H; Ying G; Dong Q; Zhang L; Yu J; Fan D; Hao X J Am Coll Surg; 2014 Nov; 219(5):904-13. PubMed ID: 25260683 [TBL] [Abstract][Full Text] [Related]
16. CD40 DNA hypermethylation in primary gastric tumors; as a novel diagnostic biomarker. Amini M; Ghorban K; Mokhtarzadeh A; Dadmanesh M; Baradaran B Life Sci; 2020 Aug; 254():117774. PubMed ID: 32407843 [TBL] [Abstract][Full Text] [Related]
17. NDRG4 hypermethylation is a potential biomarker for diagnosis and prognosis of gastric cancer in Chinese population. Chen X; Yang Y; Liu J; Li B; Xu Y; Li C; Xu Q; Liu G; Chen Y; Ying J; Duan S Oncotarget; 2017 Jan; 8(5):8105-8119. PubMed ID: 28042954 [TBL] [Abstract][Full Text] [Related]
18. Epigenetic inactivation of FAT4 contributes to gastric field cancerization. Yoshida S; Yamashita S; Niwa T; Mori A; Ito S; Ichinose M; Ushijima T Gastric Cancer; 2017 Jan; 20(1):136-145. PubMed ID: 26792292 [TBL] [Abstract][Full Text] [Related]
19. Methylation of promoter and expression silencing of GPX3 gene in hepatocellular carcinoma tissue. Cao S; Yan B; Lu Y; Zhang G; Li J; Zhai W; Guo W; Zhang S Clin Res Hepatol Gastroenterol; 2015 Apr; 39(2):198-204. PubMed ID: 25445749 [TBL] [Abstract][Full Text] [Related]
20. Hypermethylation and loss of expression of glutathione peroxidase-3 in Barrett's tumorigenesis. Lee OJ; Schneider-Stock R; McChesney PA; Kuester D; Roessner A; Vieth M; Moskaluk CA; El-Rifai W Neoplasia; 2005 Sep; 7(9):854-61. PubMed ID: 16229808 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]